Physician profile
David A Holman
NPI 1629048954
$1,449.13
in general payments reported to CMS, 2019-2025
17 companies · $79.00 in 2025
The $79.00 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.85 · 2020: $128 · 2021: $555 · 2022: $171 · 2023: $259 · 2024: $177 · 2025: $79.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $207.40 | 2021-2024 | Evenity, Prolia, Repatha |
| Janssen Pharmaceuticals, INC | $181.24 | 2019-2021 | |
| Pfizer INC. | $157.08 | 2021-2023 | |
| Lilly USA, LLC | $133.84 | 2019-2023 | Mounjaro, Jardiance, Emgality |
| Novo Nordisk INC | $122.37 | 2019-2024 | Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $118.24 | 2022-2024 | Eliquis |
| Novartis Pharmaceuticals Corporation | $111.59 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $100.67 | 2021-2025 | Farxiga |
| Avanir Pharmaceuticals, INC. | $89.71 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.71 | 2019-2021 | |
| Exact Sciences Corporation | $58.81 | 2023-2024 | Cologuard Collection Kit |
| Boston Scientific Corporation | $30.57 | 2022 | |
| Smith+Nephew, INC. | $20.34 | 2025 | Grafix |
| Organon LLC | $14.76 | 2023 | Nexplanon |
| Astellas Pharma US INC | $14.67 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $12.12 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Holman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.